{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:59:17Z","timestamp":1791377957065,"version":"4.3.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U18FD005292"],"award-info":[{"award-number":["U18FD005292"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jacc.2022.02.048","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T14:30:01Z","timestamp":1651501801000},"page":"1802-1813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S."],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-2548","authenticated-orcid":false,"given":"Adam J.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Shambhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Cziraky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara B.","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrin","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha J.","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.02.048_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.02.048_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ehjqcco\/qcy058","article-title":"Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data","volume":"5","author":"Lindh","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2022.02.048_bib3","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2022.02.048_bib4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.02.048_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.02.048_bib6","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jacl.2018.03.084","article-title":"Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease\u2014real-world experience within a large integrated health care system: the IMPRES study","volume":"12","author":"Anderson","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2022.02.048_bib8","first-page":"892","article-title":"Antihyperlipidemic medication treatment patterns and statin adherence among patients with ASCVD in a managed care plan after release of the 2013 ACC\/AHA guideline on the treatment of blood cholesterol","volume":"22","author":"Bellows","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jacc.2022.02.048_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacl.2018.04.007","article-title":"Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service","volume":"12","author":"Lamprecht","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2022.02.048_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamacardio.2016.5922","article-title":"Adoption of the 2013 American College of Cardiology\/American Heart Association cholesterol management guideline in cardiology practices nationwide","volume":"2","author":"Pokharel","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamacardio.2016.4052","article-title":"Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease","volume":"2","author":"Rodriguez","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey","volume":"2","author":"Salami","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25505","article-title":"Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016","volume":"3","author":"Yao","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2022.02.048_bib14","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2016.11.004","volume":"69","author":"Chan","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib16","article-title":"Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM registry","volume":"8","author":"Bradley","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.02.048_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ahj.2018.03.011","article-title":"Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry","volume":"200","author":"Lowenstern","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.02.048_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2020.04.018","article-title":"Beliefs, risk perceptions, and lipid management among patients with and without diabetes: results from the PALM registry","volume":"225","author":"Lowenstern","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.02.048_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.amjcard.2018.12.031","article-title":"Association of clinician knowledge and statin beliefs with statin therapy use and lipid levels (a survey of US practice in the PALM registry)","volume":"123","author":"Lowenstern","year":"2019","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2022.02.048_bib20","article-title":"Lipid testing and statin dosing after acute myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.02.048_bib21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bcp.12339","article-title":"Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review","volume":"78","author":"De Vera","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2022.02.048_bib22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/AMEP.S59022","article-title":"Factors associated with clinical inertia: an integrative review","volume":"5","author":"Aujoulat","year":"2014","journal-title":"Adv Med Educ Pract"},{"key":"10.1016\/j.jacc.2022.02.048_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacl.2015.11.002","article-title":"Provider understanding of the 2013 ACC\/AHA cholesterol guideline","volume":"10","author":"Virani","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2022.02.048_bib25","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.02.048_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12916-016-0550-5","article-title":"Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro\/con debate","volume":"14","author":"Hobbs","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2022.02.048_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2019.05.009","article-title":"Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: results from the Patient and Provider Assessment of Lipid Management (PALM) registry","volume":"214","author":"Nanna","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.02.048_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004652","article-title":"Variation in lipid-lowering therapy use in patients with low-density lipoprotein cholesterol \u2265190\u00a0mg\/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry","volume":"11","author":"Virani","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2022.02.048_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0897190019896505","article-title":"Impact of community pharmacist interventions with managed care to improve medication adherence","volume":"34","author":"Daly","year":"2021","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.jacc.2022.02.048_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCULATIONAHA.120.051913","article-title":"Digital care transformation: interim report from the first 5000 patients enrolled in a remote algorithm-based cardiovascular risk management program to improve lipid and hypertension control","volume":"143","author":"Scirica","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.02.048_bib31","doi-asserted-by":"crossref","first-page":"103593","DOI":"10.1016\/j.ebiom.2021.103593","article-title":"Outcomes of a smartphone-based application with live health-coaching post-percutaneous coronary intervention","volume":"72","author":"Paruchuri","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.jacc.2022.02.048_bib32","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1093\/ehjcvp\/pvab017","article-title":"The SAMSON trial: using a placebo to improve medication tolerability","volume":"7","author":"Nelson","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2022.02.048_bib33","doi-asserted-by":"crossref","first-page":"n135","DOI":"10.1136\/bmj.n135","article-title":"Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials","volume":"372","author":"Herrett","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2022.02.048_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacl.2014.09.007","article-title":"Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial","volume":"8","author":"Moriarty","year":"2014","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2022.02.048_bib35","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2016.3608","article-title":"Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2022.02.048_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/CIRCRESAHA.118.313171","article-title":"Lipid-lowering agents","volume":"124","author":"Hegele","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2022.02.048_bib37","doi-asserted-by":"crossref","first-page":"NP136","DOI":"10.1177\/1557988315590836","article-title":"Perceptions related to cardiovascular disease risk in Caucasian college males","volume":"10","author":"Abshire","year":"2016","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.jacc.2022.02.048_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamacardio.2018.1511","article-title":"Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the Patient and Provider Assessment of Lipid Management Registry","volume":"3","author":"Nanna","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006548","article-title":"Patient-perceived versus actual risk of cardiovascular disease and associated willingness to consider and use prevention therapy","volume":"14","author":"Navar","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2022.02.048_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/RMHP.S8288","article-title":"Perceptions of risk: understanding cardiovascular disease","volume":"3","author":"Webster","year":"2010","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/j.jacc.2022.02.048_bib41","first-page":"1302785","article-title":"Health information seeking in the digital age: An analysis of health information seeking behavior among US adults","volume":"3","author":"Jacobs","year":"2017","journal-title":"Cogent Soc Sci"},{"key":"10.1016\/j.jacc.2022.02.048_bib42","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.2196\/jmir.3992","article-title":"eHealth literacy and Web 2.0 health information seeking behaviors among baby boomers and older adults","volume":"17","author":"Tennant","year":"2015","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.jacc.2022.02.048_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11883-020-00853-9","article-title":"Statins in a distorted mirror of media","volume":"22","author":"Nelson","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2022.02.048_bib44","first-page":"189","article-title":"Coronary artery disease in the young in the US population-based cohort","volume":"10","author":"Krittanawong","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2022.02.048_bib45","article-title":"Risk factor burden and long-term prognosis of patients with premature coronary artery disease","volume":"9","author":"Zeitouni","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.02.048_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCOUTCOMES.110.957720","article-title":"Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22","volume":"4","author":"Truong","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2022.02.048_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.1016\/j.jacc.2022.02.048_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/diagnostics10070483","article-title":"Cardiovascular risk and statin therapy considerations in women","volume":"10","author":"Gheorghe","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jacc.2022.02.048_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11606-006-5042-4","article-title":"Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease","volume":"12","author":"McDermott","year":"1997","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2022.02.048_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2020.05.048","article-title":"Atherosclerotic risk and statin use among patients with peripheral artery disease","volume":"76","author":"Colantonio","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.02.048_bib51","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.02.048_bib52","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722009421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722009421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T18:54:55Z","timestamp":1722452095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722009421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":52,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0735109722009421"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.02.048","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742130180.793593922","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}